N/A
N=60
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
Alcohol-Related Disorders · Liver Diseases
Bottom Line
View on ClinicalTrials.gov: NCT04473482 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Feasibility of MAIN-ART Tool as Measured by Recruitment Rates — 60 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Michigan
- Primary completion
- Jun 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of MAIN-ART Tool as Measured by Recruitment Rates |
60 | — |
| PRIMARY Feasibility of MAIN-ART Tool as Measured by Retention Rates |
19; 19 | — |
| PRIMARY Acceptability of the MAIN-ART Tool as Measured by Post-intervention Surveys |
70 | — |
| SECONDARY Alcohol Use Frequency as Measured by the Alcohol Timeline Follow-back (TLFB) Interview |
87; 72; 13; 29 | — |
| SECONDARY Alcohol Treatment Engagement as Measured by Number of Participants Who Engaged in Any Alcohol Cessation or Reduction Visit as Measured by Self-report. |
8; 4 | — |
Summary
The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.
Eligibility Criteria
Inclusion Criteria
- Enrolled at University of Michigan general hepatology clinics or inpatient wards
- Documented diagnosis of alcohol-associated cirrhosis or alcoholic hepatitis or alcohol-related liver disease of any stage
- Drinking of any amount of alcohol within the 6 months prior to recruitment
- No alcohol use treatment within the past 1 month
- Access to a phone for purposes of follow-up
Exclusion Criteria
- Active alcohol use treatment
- Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation.
- Is enrolled in the multidisciplinary alcohol-related liver disease clinic at Michigan Medicine
Data sourced from ClinicalTrials.gov (NCT04473482). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.